4//SEC Filing
Shak Steven 4
Accession 0001209191-19-044569
CIK 0001131324other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:35 PM ET
Size
9.4 KB
Accession
0001209191-19-044569
Insider Transaction Report
Form 4
Shak Steven
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-08-01$73.22/sh−7,372$539,807→ 158,795 total(indirect: By Trust) - Sale
Common Stock
2019-08-02$72.43/sh−25,000$1,810,857→ 133,795 total(indirect: By Trust) - Sale
Common Stock
2019-08-01$72.72/sh−17,628$1,281,977→ 166,167 total(indirect: By Trust)
Footnotes (6)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2019.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $72.04 to $73.02.
- [F4]Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $73.04 to $73.56.
- [F6]Represents weighted average sale price. Actual sale prices ranged from $71.985 to $72.72.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001337334
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:35 PM ET
- Size
- 9.4 KB